share_log

Galectin Therapeutics | 8-K/A: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

SEC ·  Nov 13, 2023 09:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more